Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 406

1.

Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.

Buonpane RA, Moza B, Sundberg EJ, Kranz DM.

J Mol Biol. 2005 Oct 21;353(2):308-21.

PMID:
16171815
2.

Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes.

McCormick JK, Tripp TJ, Llera AS, Sundberg EJ, Dinges MM, Mariuzza RA, Schlievert PM.

J Immunol. 2003 Aug 1;171(3):1385-92.

3.

High affinity T cell receptors from yeast display libraries block T cell activation by superantigens.

Kieke MC, Sundberg E, Shusta EV, Mariuzza RA, Wittrup KD, Kranz DM.

J Mol Biol. 2001 Apr 13;307(5):1305-15.

PMID:
11292343
5.

Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1.

Acharya KR, Passalacqua EF, Jones EY, Harlos K, Stuart DI, Brehm RD, Tranter HS.

Nature. 1994 Jan 6;367(6458):94-7.

PMID:
8107781
7.

Modeling of receptor mimics that inhibit superantigen pathogenesis.

Möllhoff M, Zanden HB, Shiflett PR, Gupta G.

J Mol Recognit. 2005 Jan-Feb;18(1):73-83.

PMID:
15459942
8.

Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.

Hurley JM, Shimonkevitz R, Hanagan A, Enney K, Boen E, Malmstrom S, Kotzin BL, Matsumura M.

J Exp Med. 1995 Jun 1;181(6):2229-35.

9.

The T cell receptor beta-chain second complementarity determining region loop (CDR2beta governs T cell activation and Vbeta specificity by bacterial superantigens.

Nur-ur Rahman AK, Bonsor DA, Herfst CA, Pollard F, Peirce M, Wyatt AW, Kasper KJ, Madrenas J, Sundberg EJ, McCormick JK.

J Biol Chem. 2011 Feb 11;286(6):4871-81. doi: 10.1074/jbc.M110.189068. Epub 2010 Dec 2.

10.

Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.

Fernández MM, Bhattacharya S, De Marzi MC, Brown PH, Kerzic M, Schuck P, Mariuzza RA, Malchiodi EL.

Proteins. 2007 Jul 1;68(1):389-402.

PMID:
17427250
11.

Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.

von Bonin A, Ehrlich S, Malcherek G, Fleischer B.

Eur J Immunol. 1995 Oct;25(10):2894-8.

PMID:
7589089
12.

Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.

Newton DW, Dohlsten M, Olsson C, Segrén S, Lundin KE, Lando PA, Kalland T, Kotb M.

J Immunol. 1996 Nov 1;157(9):3988-94.

PMID:
8892632
13.

Design of chimeric receptor mimics with different TcRVbeta isoforms. Type-specific inhibition of superantigen pathogenesis.

Hong-Geller E, Möllhoff M, Shiflett PR, Gupta G.

J Biol Chem. 2004 Feb 13;279(7):5676-84. Epub 2003 Nov 6.

14.

Structural basis of T-cell specificity and activation by the bacterial superantigen TSST-1.

Moza B, Varma AK, Buonpane RA, Zhu P, Herfst CA, Nicholson MJ, Wilbuer AK, Seth NP, Wucherpfennig KW, McCormick JK, Kranz DM, Sundberg EJ.

EMBO J. 2007 Feb 21;26(4):1187-97. Epub 2007 Feb 1.

15.

Molecular basis of TCR selectivity, cross-reactivity, and allelic discrimination by a bacterial superantigen: integrative functional and energetic mapping of the SpeC-Vbeta2.1 molecular interface.

Rahman AK, Herfst CA, Moza B, Shames SR, Chau LA, Bueno C, Madrenas J, Sundberg EJ, McCormick JK.

J Immunol. 2006 Dec 15;177(12):8595-603.

16.

Epitope mapping of neutralizing TSST-1 specific antibodies induced by immunization with toxin or toxoids.

Gampfer JM, Samstag A, Waclavicek M, Wolf HM, Eibl MM, Gulle H.

Vaccine. 2002 Nov 1;20(31-32):3675-84.

PMID:
12399195
17.
19.

Crystal structure of a T-cell receptor beta-chain complexed with a superantigen.

Fields BA, Malchiodi EL, Li H, Ysern X, Stauffacher CV, Schlievert PM, Karjalainen K, Mariuzza RA.

Nature. 1996 Nov 14;384(6605):188-92.

PMID:
8906797
20.

Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.

Brogan PA, Shah V, Klein N, Dillon MJ.

Arthritis Rheum. 2004 Feb;50(2):589-97.

Items per page

Supplemental Content

Write to the Help Desk